Related Experiment Video
Updated: Feb 16, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
Mixed histiocytosis: A case report and published work review
Zhongtao Li1, Yun Li1, Weiping Liu2
1Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China.
This study reports a rare case of mixed histiocytosis in an adult Chinese man, combining eosinophilic granuloma with cutaneous plane xanthoma. This exceptional comorbidity highlights the diverse presentations of histiocytic disorders.
Area of Science:
- Dermatology
- Pathology
- Oncology
Background:
- Histiocytoses comprise Langerhans cell histiocytosis (LCH) and non-Langerhans cell histiocytosis (NLCH).
- Cutaneous plane xanthoma (CPX) is an NLCH presenting as yellow-orange plaques, often linked to systemic conditions.
- Eosinophilic granuloma (EG) is an LCH primarily affecting bone in children.
Observation:
- A case of EG in an adult Chinese male with concurrent CPX on the scalp and face is presented.
- This represents an exceptional instance of mixed histiocytosis, combining LCH and NLCH in one patient.
- Review of existing literature on comorbid EG and NLCH cases was conducted.
Findings:
- The patient exhibited both EG and CPX, a rare mixed histiocytosis.
- This case is the first reported instance of mixed histiocytosis involving CPX and EG in China.
- The review identified limited published cases of EG co-occurring with NLCH.
Implications:
- This case expands the understanding of histiocytic disorder presentations.
- It underscores the importance of considering diverse histiocytic involvements in clinical diagnosis.
- Further research into the mechanisms and management of mixed histiocytoses is warranted.
More Related Videos
11:26Isolation and Immortalization of Patient-derived Cell Lines from Muscle Biopsy for Disease Modeling
Published on: January 18, 2015
09:44Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
Published on: September 5, 2019